REPORTS

Let’s Pullulate and Expand Your Business

Drug–Device Combination Products Market - Global Professional Analysis and Forecast to 2026

Feb 24, 2020  |  175 PAGES  |  REPORT CODE: CMM268527
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Drug–Device Combination Products market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 8.6% during the forecast period.

This report presents the market size and development trends by detailing the Drug–Device Combination Products market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Drug–Device Combination Products market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Drug–Device Combination Products industry and will help you to build a panoramic view of the industrial development.

Drug–Device Combination Products Market, By Type:

  • Infusion Pumps

  • Orthopedic Combination Products

  • Photodynamic Therapy Devices

  • Transdermal Patches

  • Drug Eluting Stents

  • Wound Care Products

  • Inhalers

  • Other

Drug–Device Combination Products Market, By Application:

  • Hospital

  • Clinic

  • Other

Some of the leading players are as follows:

  • Abbott

  • Terumo Corporation

  • Allergan

  • Stryker Corporation

  • C.R. Bard

  • Teleflex Incorporated

  • Boston Scientific

  • Medtronic

  • Mylan

  • Novartis

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Drug–Device Combination Products Market: Technology Type Analysis

  • 4.1 Drug–Device Combination Products Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Drug–Device Combination Products Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Infusion Pumps

    • 4.3.2 Orthopedic Combination Products

    • 4.3.3 Photodynamic Therapy Devices

    • 4.3.4 Transdermal Patches

    • 4.3.5 Drug Eluting Stents

    • 4.3.6 Wound Care Products

    • 4.3.7 Inhalers

    • 4.3.8 Other

5 Drug–Device Combination Products Market: Product Analysis

  • 5.1 Drug–Device Combination Products Product Market Share Analysis, 2018 & 2026

  • 5.2 Drug–Device Combination Products Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Drug–Device Combination Products Market: Application Analysis

  • 6.1 Drug–Device Combination Products Application Market Share Analysis, 2018 & 2026

  • 6.2 Drug–Device Combination Products Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospital

    • 6.3.2 Clinic

    • 6.3.3 Other

7 Drug–Device Combination Products Market: Regional Analysis

  • 7.1 Drug–Device Combination Products Regional Market Share Analysis, 2018 & 2026

  • 7.2 Drug–Device Combination Products Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 Abbott

    • 9.1.1 Abbott Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Terumo Corporation

    • 9.2.1 Terumo Corporation Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Allergan

    • 9.3.1 Allergan Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Stryker Corporation

    • 9.4.1 Stryker Corporation Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 C.R. Bard

    • 9.5.1 C.R. Bard Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Teleflex Incorporated

    • 9.6.1 Teleflex Incorporated Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 Boston Scientific

    • 9.7.1 Boston Scientific Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Medtronic

    • 9.8.1 Medtronic Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Mylan

    • 9.9.1 Mylan Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Novartis

    • 9.10.1 Novartis Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 98 Figures and 131 Tables)

  • Figure Infusion Pumps Drug–Device Combination Products market, 2015 - 2026 (USD Million)

  • Figure Orthopedic Combination Products Drug–Device Combination Products market, 2015 - 2026 (USD Million)

  • Figure Photodynamic Therapy Devices Drug–Device Combination Products market, 2015 - 2026 (USD Million)

  • Figure Transdermal Patches Drug–Device Combination Products market, 2015 - 2026 (USD Million)

  • Figure Drug Eluting Stents Drug–Device Combination Products market, 2015 - 2026 (USD Million)

  • Figure Wound Care Products Drug–Device Combination Products market, 2015 - 2026 (USD Million)

  • Figure Inhalers Drug–Device Combination Products market, 2015 - 2026 (USD Million)

  • Figure Other Drug–Device Combination Products market, 2015 - 2026 (USD Million)

  • Figure Hospital market, 2015 - 2026 (USD Million)

  • Figure Clinic market, 2015 - 2026 (USD Million)

  • Figure Other market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Drug–Device Combination Products market, by country, 2015 - 2026 (USD Million)

  • Table North America Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table North America Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table North America Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table Canada Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table Canada Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Europe Drug–Device Combination Products market, by country, 2015 - 2026 (USD Million)

  • Table Europe Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table Europe Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table Europe Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table Germany Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table Germany Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table France Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table France Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table Italy Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table Italy Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table Spain Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table Spain Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Drug–Device Combination Products market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table China Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table China Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table Japan Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table Japan Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table India Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table India Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Drug–Device Combination Products market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table MEA Drug–Device Combination Products market, by country, 2015 - 2026 (USD Million)

  • Table MEA Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table MEA Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table MEA Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Drug–Device Combination Products market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Drug–Device Combination Products market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Drug–Device Combination Products market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table Abbott Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Terumo Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Allergan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Stryker Corporation Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table C.R. Bard Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Teleflex Incorporated Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Boston Scientific Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Medtronic Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Mylan Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Novartis Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top